Balance Sheet Data

BIOLASE, Inc. (BIOL)

$1.11

-0.03 (-2.63%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 8.045.7917.5629.974.1820.6822.6424.7827.1329.70
Total Cash (%)
Account Receivables 11.118.763.064.245.848.869.7010.6211.6312.73
Account Receivables (%)
Inventories 12.2510.9911.1612.9315.8818.0819.7921.6623.7125.95
Inventories (%)
Accounts Payable 5.955.332.653.315.796.266.857.508.218.99
Accounts Payable (%)
Capital Expenditure -0.56-0.21-0.10-0.71-3.73-1.24-1.36-1.48-1.62-1.78
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.